|
|
| Medicalboard |
 |
Amar
Gajjar, MD
St. Jude Children's Research Hospital
Memphis, TN
Member
of St. Jude Faculty, Co-Chair, Department
of Oncology, Director, Neuro-Oncology
Division, Co-Leader, Neurobiology &
Brain Tumor Program
Dr.
Gajjar's current clinical research interests
focus on innovative protocols for the
treatment of childhood brain tumors, with
a focus on medulloblastomas, PNET and
Rhabdoid tumors (ATRT). He is working
with investigators in basic science laboratories
to develop new chemotherapeutic agents
for the treatment of brain tumors.
|
|
|
Dr.
John L. Cleveland
The Scripps Research Institute
Boca Raton, FL
The
Scripps Research Institute-Florida, Chairman
of the Department of Cancer Biology. Editor
of Molecular and Cellular Biology, Molecular
Cancer Research, and Cell Death & Differentiation
and as Associate Editor for Molecular Biology
of the Cell
Dr.
Cleveland currently serves as a Member
of the Extramural Scientific Advisory
Boards for Cancer Center and SPORE programs
for The Roswell Park Cancer Institute,
The University of Arizona and, most recently,
as a member of the Extramural Advisory
Board for The Blood Research Institute
(University of Wisconsin).
Dr.
Cleveland is also a member of the Developmental
Biology study section of the American
Cancer Society for 6 years, as a member
of the NIH study section HEM-1 for 5 years,
and he is now a member of the NCI-C Program
Project Grant Review Parent Committee.
|
|
 |
Stewart
Goldman, MD
Children's Memorial Hospital
Chicago, IL
Member
of Children's Memorial Hospital, Medical
Director, Neuro-oncology, Gus Foundation
Chair of Neuro-oncology, Board Certified
in Pediatric Hematology, Oncology and Pediatrics.
Member of the Pediatric Brain Tumor Consortium
Dr. Goldman, a cancer specialist and medical
director of Children's Memorial Hospital's
Neuro-Oncology unit, Dr. Goldman has participated
in important studies of Hodgkin's disease
and brain tumor treatments. He is committed
to discovering and teaching new treatment
techniques as an associate professor of
pediatrics at Northwestern University. Dr.
Goldman earned his medical degree at Loyola
University's Strich School of Medicine. |
|
|
 |
Sridharan
Gururangan, MRCP (UK)
Duke Medical Center
Durham, NC
Director
of Pediatric Clinical Services, Associate Professor
of Pediatrics, Associate Professor of Surgery
Dr. Gururangan
is a pediatric neuro-oncologist responsible
for designing and providing care to children
with brain and spinal cord tumors. Dr. "Sri"
Gururangan focuses exclusively on the clinical
care of children with brain tumors. Over the
last 10 years, he has had extensive experience
in the treatment of children with cancers, particularly
brain tumors, in several premier institutions
in the United States, England, Ireland, and
most recently at Memorial Sloan-Kettering Cancer
Center in New York. He designs clinical protocols,
which utilize the newest advances in the treatment
of children with these tumors.
|
|
 |
Regina
I. Jakacki, MD
Children's Hospital of Pittsburgh
Pittsburgh, PA
Director,
Neuro-Oncology Program, Medical Director, Supportive
Care Program, Associate Professor of Pediatrics,
University of Pittsburgh School of Medicine
Dr. Jakacki received her PhD in 1985 from the
University of Pennsylvania in Philadelphia, PA
. She is part of the American Board of Pediatrics,
Pediatric Hematology/Oncology, and American Board
of Hospice and Palliative Medicine. Dr. Jakacki
has two publications including: "Treatment
strategies for high-risk medulloblastomas and
supratentorial primitive neuroectodermal tumors."
and "A pilot study of pre-irradiation chemotherapy
and low-dose craniospinal irradiation in young
children with medulloblastoma." |
|
 |
Mark
W. Kieran, MD, PhD
Dana-Farber Cancer Institute
Boston, MA
Assistant
Professor of Pediatrics, Harvard Medical School
Dr. Kieran received his PhD in 1984 from the University
of Alberta, Edmonton, Canada, and his MD in 1986
from the University of Calgary. He completed postgraduate
training in molecular biology at the Pasteur Institute
in Paris. After a pediatric residency in Montreal,
he received postdoctoral education at Children's
Hospital Boston. In 1997, he became director of
Pediatric Medical Neuro-Oncology at DFCI. He also
works on angiogenesis in the laboratory of Dr.
Judah Folkman. |
|
 |
Larry
E. Kun, MD
St. Jude Children's Research Hospital
Memphis, TN
Member
and Chairman, Department of Radiation Oncology
St. Jude Children's Research Hospital, Co-Program
Leader
Neurobiology and Brain Tumor Program St. Jude
Children's Research Hospital, Radiological Sciences
Chair
Dr. Kun participates in the Children's Oncology
Group as Co-Chairman of the Brain Tumor Committee
and is the principal investigator to the National
Cancer Institute's Pediatric Brain Tumor Consortium
for St. Jude Children's Research Hospital. |
|
 |
Christopher
Lawlor, MD
Pediatrics-Children’s National Medical Center
Washington , DC
Member
of Pediatric Hematology/Oncology-Children’s
National Medical Center, Assistant Professor of
Pediatrics at George Washington University Medical
School, Assistant
Medical Directorship of Outpatient Services for
the Center of Cancer and Blood Disorders in Northern
Virginia.
Dr.
Lawlor completed medical school in 1996, graduating
from New York Medical College. He is Board certified
in both Pediatric and Hematology/Oncology and
has done research concentrating
on the expression profiling of medulloblastomas,
gliomas and the Ewing sarcoma family of tumors.
|
|
|
|
|
